{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-24-007372","form_type":"8-K","ticker":null,"cik":"0000910267","company_name":"TITAN PHARMACEUTICALS INC","filed_at":"2024-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.349849+00:00","generated_at":"2026-05-30T03:10:24.058576+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Titan Pharmaceuticals appoints director Brynner Chiam as acting CEO and CFO","bullets":["Brynner Chiam appointed acting principal executive officer and principal financial officer effective November 6, 2024.","Company has launched a search for a full-time CEO; Chiam receives no additional compensation.","Chiam is Tax Director at Black Chamber Management with over 20 years of tax consulting experience."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-24-007372","json":"https://secwatch.observer/filing/0001829126-24-007372.json","markdown":"https://secwatch.observer/filing/0001829126-24-007372.md","text":"https://secwatch.observer/filing/0001829126-24-007372.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/910267/000182912624007372/0001829126-24-007372-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/910267/000182912624007372/titanpharma_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T03:10:24.058576+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bc6f7ea73e","claim":"Brynner Chiam was appointed as acting principal executive officer and acting principal financial officer at TITAN PHARMACEUTICALS INC.","evidence_excerpt":"On November 6, 2024, the Board of Directors of Titan Pharmaceuticals, Inc. (the “Company”) appointed Brynner Chiam, a director of the Company, as acting principal executive officer and acting principal financial officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/910267/000182912624007372/0001829126-24-007372-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"acting principal executive officer and acting principal financial officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}